"Cholangitis, Sclerosing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
Descriptor ID |
D015209
|
MeSH Number(s) |
C06.130.120.200.110
|
Concept/Terms |
Cholangitis, Sclerosing- Cholangitis, Sclerosing
- Cholangitides, Sclerosing
- Sclerosing Cholangitides
- Sclerosing Cholangitis
- Cholangiitis, Sclerosing
- Cholangiitides, Sclerosing
- Sclerosing Cholangiitides
- Sclerosing Cholangiitis
Primary Sclerosing Cholangitis- Primary Sclerosing Cholangitis
- Cholangitides, Primary Sclerosing
- Primary Sclerosing Cholangitides
- Sclerosing Cholangitides, Primary
- Sclerosing Cholangitis, Primary
- Cholangitis, Primary Sclerosing
|
Below are MeSH descriptors whose meaning is more general than "Cholangitis, Sclerosing".
Below are MeSH descriptors whose meaning is more specific than "Cholangitis, Sclerosing".
This graph shows the total number of publications written about "Cholangitis, Sclerosing" by people in this website by year, and whether "Cholangitis, Sclerosing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 11 | 2 | 13 |
2018 | 13 | 2 | 15 |
2019 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholangitis, Sclerosing" by people in Profiles.
-
Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep. 2021 Aug 26; 14(8).
-
New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant? J Hepatol. 2022 01; 76(1):218-220.
-
A case of secondary sclerosing cholangitis due to COVID-19. Clin Imaging. 2021 Dec; 80:239-242.
-
Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int. 2021 10; 41(10):2404-2417.
-
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021 07 01; 116(7):1414-1425.
-
Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients. Intensive Care Med. 2021 09; 47(9):1037-1040.
-
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19. Hepatology. 2021 07; 74(1):519-521.
-
[80-year-old patient with jaundice after a severe Covid-19 infection]. Dtsch Med Wochenschr. 2021 01; 146(1):13-14.
-
Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Rep. 2020 Nov 09; 13(11).
-
COVID-19 and Jaundice. Gastroenterology. 2021 Jun; 160(7):e1-e3.